Logo image of AMRX

AMNEAL PHARMACEUTICALS INC (AMRX) Stock Analyst Ratings

NASDAQ:AMRX - Nasdaq - US03168L1052 - Common Stock - Currency: USD

8.13  +0.22 (+2.72%)

After market: 8.2 +0.07 (+0.86%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to AMRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.9. This target is 46.37% above the current price.
AMRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about AMRX.
In the previous month the buy percentage consensus was at a similar level.
AMRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
AMRX Historical Analyst RatingsAMRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 8.1311.1112.2411.9012.60 - 36.65% 50.55% 46.37% 54.98%
AMRX Current Analyst RatingAMRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-03-03 Barclays Maintains Overweight -> Overweight
2025-02-24 JP Morgan Upgrade Neutral -> Overweight
2024-11-11 Piper Sandler Maintains Overweight -> Overweight
2024-10-02 Truist Securities Maintains Buy -> Buy
2024-09-06 JP Morgan Upgrade Underweight -> Neutral
2024-08-13 Barclays Maintains Overweight -> Overweight
2024-08-12 Truist Securities Maintains Buy -> Buy
2024-05-06 Truist Securities Reiterate Buy -> Buy
2024-05-06 Goldman Sachs Maintains Buy -> Buy
2024-03-21 Piper Sandler Maintains Overweight -> Overweight
2024-03-04 Goldman Sachs Maintains Buy -> Buy
2024-01-29 Barclays Maintains Overweight -> Overweight
2023-11-08 Truist Securities Maintains Buy -> Buy
2023-09-06 Truist Securities Reiterate Buy -> Buy
2023-08-07 Barclays Maintains Overweight -> Overweight
2023-08-07 Truist Securities Maintains Buy -> Buy
2023-08-07 Piper Sandler Maintains Overweight -> Overweight
2023-05-08 Piper Sandler Maintains Overweight
2023-03-29 Truist Securities Maintains Buy
2023-03-10 Barclays Maintains Overweight
2023-03-03 BMO Capital Maintains Market Perform
2023-03-03 Goldman Sachs Maintains Buy
2022-08-08 Goldman Sachs Maintains Buy
2022-05-12 Goldman Sachs Maintains Buy
2021-03-08 Goldman Sachs Upgrade Sell -> Buy